NCT04157985 2025-12-11Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid TumorsUniversity of PittsburghPhase 3 Completed161 enrolled
NCT04008030 2025-10-03CheckMate 8HWBristol-Myers SquibbPhase 3 Active not recruiting839 enrolled 22 charts 1 FDA